Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism

Abstract

The invention relates to plasminogen activator-1 (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or condition associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to modulate lipid metabolism and treat conditions associated with elevated PAI-1, cholesterol, or lipid levels.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 4, 2015
  • Application: May 21, 2014
    US US 201414284021 A
  • Priority: May 21, 2014
    US US 201414284021 A
  • Priority: Apr 16, 2008
    US US 10440908 A
  • Priority: Apr 16, 2007
    US US 91207107 P

Download Citation


Sign in to the Lens

Feedback